APA (7th ed.) Citation

Zannad, F., Ferreira, J. P., Pocock, S. J., Zeller, C., Anker, S. D., Butler, J., . . . Packer, M. (2021). Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from EMPEROR-reduced. Circulation, 143(4), . https://doi.org/10.1161/CIR.0000000000000953

Chicago Style (17th ed.) Citation

Zannad, Faiez, et al. "Correction to: Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from EMPEROR-reduced." Circulation 143, no. 4 (2021). https://doi.org/10.1161/CIR.0000000000000953.

MLA (9th ed.) Citation

Zannad, Faiez, et al. "Correction to: Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from EMPEROR-reduced." Circulation, vol. 143, no. 4, 2021, https://doi.org/10.1161/CIR.0000000000000953.